Celltrion Inc

#Biosimilars positively impact not only individual patient access to treatment but also the healthcare system as a whole. Listen to our interview with Prof. João Manuel Braz Gonçalves, Full Professor in Faculty of Pharmacy at Universidade de Lisboa, in which he discusses the impact of biosimilars on healthcare systems.

Recognizing International Women's Day, we celebrate the achievements of women from all backgrounds, no matter their nationality, ethnicity, or culture. 🌍 To honor #IWD, we asked Candice KLELE, Chief Pharmaceutical Officer, Pharmaceutical Affairs Director, PharmD at Celltrion France to share what inspires her in her career. Discover her inspiring insights and join us in recognizing the women who are driving innovation at Celltrion and making a powerful impact every day. 💪🙌 #AccelrateAction

Today is International Women's Day, a day to celebrate the achievements of women from all backgrounds, no matter their nationality, ethnicity, or culture. 🌍 To honor #IWD, we asked Min Kyoung Jeon, Ph.D., Vice President and Head of Regulatory Affairs Division at Celltrion to share what inspires her in her career. Discover her inspiring insights and join us in recognizing the women who are driving innovation at Celltrion and making a powerful impact every day. 💪🙌 #AccelrateAction

💡 2025년 1차 신입/경력 수시채용에 많은 관심 부탁드립니다. 👉 채용 공고 : https://lnkd.in/evPCaZvN

Ahead of this year's International Women's Day, we celebrate the achievements of women from all backgrounds, no matter their nationality, ethnicity, or culture. 🌍 To honor #IWD, we asked incredible women at Celltrion to share what inspires them in their careers. Discover their inspiring insights and join us in recognizing the women who are driving innovation at Celltrion and making a powerful impact every day. 💪🙌 #AccelrateAction Rositsa Desjardin Anne Peter Camille CLIDASSOU

As global citizens, we believe it is our responsibility to preserve the health and cleanliness of our planet. 🌍 At Celltrion, we are dedicated to environmental sustainability, and we continuously aim to minimizing our environmental impact and drive positive change for a better future. 🌱 Find out more at: https://bit.ly/42irB6t #ESG #Environmental

Today we announced our full year and Q4 2024 earnings release. Read full report at: https://bit.ly/4dBPTLc

BREAKING NEWS: We are delighted to announce that the European Commission has approved Celltrion’s treatment for #rheumatic diseases. This represents a significant advancement in our commitment to people living with autoimmune diseases in Europe. View press release here: https://bit.ly/4kqOPOv

We are excited to launch our first on-site congress activity of 2025 at this year’s ECCO! Come by Booth 15 at Hall 2.2b (Level 2) and discover our unwavering commitment to pursuing scientific solutions for patients with pressing unmet needs. 💡 #ECCO2025

Today, at #ECCO2025, we presented our latest data, which includes multiple post hoc analyses from the LIBERTY study. These insights underscore our commitment to improving patient outcomes through breakthrough #IBD research. View the press release here: https://bit.ly/3Qrhuov